Cetirizine 10mg Syrup Dossier Evaluation
Phase
evaluation
Deal Value
$50,000.00
upfront
End Date
Open
Key Milestone
N/A
Project Details
Supplier
Pioneer PharmaLead Department
Business DevelopmentStart Date
March 10th, 2024
End Date
Open Ended
Financial Terms
upfront
Renewal Term
none
Project ID
PXG-LIC-2024-002
Dossier Status
submitted
Project History
Mar 10, 2024
11:00 AM
Initial commercial offer received for evaluation.
Dossier Review Hub
Track due diligence progress across key departments.
Business Development
Regulatory Affairs
R&D
Supply Chain
Legal & IP
Attachments
All related documents.
No attachments found.